Model-informed drug discovery and development approaches to inform clinical trial design and regulatory decisions: A primer for the MENA region

Model-informed drug discovery and development approaches to inform clinical trial design and regulatory decisions: A primer for the MENA region

Model-Informed Drug Discovery and Development (MID3) represents a transformative approach in pharmaceutical research, integrating quantitative models to inform and optimize decision-making throughout the drug development process. This review explores the current applications, challenges, and future...

Full description

Saved in:
Bibliographic Details
Main Authors: Mohammed S. Alasmari, Salwa Albusaysi, Marwa Elhefnawy, Ali M. Ali, Khalid Altigani, Mohammed Almoslem, Mohammed Alharbi, Jahad Alghamdi, Abdullah Alsultan
Format: Article
Language:English
Published: Elsevier 2024-12-01
Series:Saudi Pharmaceutical Journal
Subjects:
Drug development
PK/PD
PBPK
MENA region
Clinical trials
Pharmacometrics
Online Access:http://www.sciencedirect.com/science/article/pii/S1319016424002585
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

http://www.sciencedirect.com/science/article/pii/S1319016424002585

Similar Items